Myxomatóza virové vakcíny - search results

European Union - English - EMA (European Medicines Agency)

nobivac myxo-rhd plus

intervet international b.v. - live myxoma vectored rhd virus strain 009, live myxoma vectored rhd virus strain mk1899 - immunologicals for leporidae - rabbits - for active immunisation of rabbits from 5 weeks of age onwards to reduce mortality and clinical signs of myxomatosis and rabbit haemorrhagic disease (rhd) caused by classical rhd virus (rhdv1) and rhd type 2 virus (rhdv2).

Germany - English - HMA (Heads of Medicines Agencies)

dercunimix

merial - inactivated rabbit haemorrhagic disease 5 pd90, myxomatosis virus attenuated 2.7 log10 ccid50 - lyophilisate and solvent - rabbit - live myxomatosis virus + inactivated rabbit haemorrhagic disease virus

Spain - English - HMA (Heads of Medicines Agencies)

dercunimix

France - English - HMA (Heads of Medicines Agencies)

dercunimix

Italy - English - HMA (Heads of Medicines Agencies)

dercunimix

Netherlands - English - HMA (Heads of Medicines Agencies)

dercunimix

Portugal - English - HMA (Heads of Medicines Agencies)

dercunimix

European Union - English - EMA (European Medicines Agency)

nobivac myxo-rhd

intervet international bv - live myxoma-vectored rabbit-haemorrhagic-disease virus strain 009 - immunologicals - rabbits - for active immunisation of rabbits from five weeks of age onwards to reduce mortality and clinical signs of myxomatosis and to prevent mortality due to rabbit haemorrhagic disease.onset of immunity: 3 weeks.duration of immunity: 1 year.

Singapore - English - HSA (Health Sciences Authority)

optiray 350 prefilled syringe 100ml

transmedic pte ltd - ioversol - injection, solution - 741 mg/ml - ioversol 741 mg/ml

Singapore - English - HSA (Health Sciences Authority)

optiray 350 prefilled syringe 125ml

transmedic pte ltd - ioversol - injection, solution - 741 mg/ml - ioversol 741 mg/ml